MedTrace Logo

Extracorporeal Cytokine Removal in Patients With Septic Shock in an Adult Intensive Care Unit

NCT04231695 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2020-01-18

No results posted yet for this study

Summary

Goals Primary: compare changes in norepinephrine requirements before and after hemoperfusion (HP) treatment.

Secondary: demonstrate the decrease in levels of IL-6 , assess the total and individual change of SEQUENTIAL ORGAN FAILURE ASSESSMENT (SOFA), establish the resolution of shock , clearance of lactate , and mortality at discharge from INTENSIVE CARE UNIT (ICU), at 30 and 60 days.

Conditions

  • Septic Shock

Sponsors & Collaborators

  • Hospital Jose Maria Cullen

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2020-12-31
Completion
2021-12-31

Countries

  • Argentina

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04231695 on ClinicalTrials.gov